| | |
Some prominent plaintiffs’ law firms are betting on the potential for future litigation with a stepped-up ad campaign targeting the cancer risk associated with the laparoscopic power morcellator gynecological surgical device.
With an advertising push led by the New York firm Weitz & Luxenberg and Maryland attorney Peter Angelos, law firms spent over $1 million to air over 1,300 morcellator mass tort ads in August.
With an advertising push led by the New York firm Weitz & Luxenberg and Maryland attorney Peter Angelos, law firms spent over $1 million to air over 1,300 morcellator mass tort ads in August.
The combined ad campaign cast a wide net for potential plaintiffs with over 60% of the ads airing on national broadcast and cable channels and other ads appearing on local stations across the country.
The heightened interest in the product follows an FDA warning in April about a possible cancer risk associated with the products. Johnson & Johnson, the largest manufacturer of the device, withdrew them from the market in late July.
Despite these actions, doctors nationwide continue to use the device claiming that the risks have been overstated.
Wall Street Journal video on power morcellator risk:
Despite these actions, doctors nationwide continue to use the device claiming that the risks have been overstated.
Wall Street Journal video on power morcellator risk:
RSS Feed
